scholarly journals Evaluation of Human Amniotic Membrane as a Wound Dressing for Split-Thickness Skin-Graft Donor Sites

2014 ◽  
Vol 2014 ◽  
pp. 1-12 ◽  
Author(s):  
Denys J. Loeffelbein ◽  
Nils H. Rohleder ◽  
Matthias Eddicks ◽  
Claudia M. Baumann ◽  
Mechthild Stoeckelhuber ◽  
...  

Human amniotic membrane (HAM) has been used as a biomaterial in various surgical procedures and exceeds some qualities of common materials. We evaluated HAM as wound dressing for split-thickness skin-graft (STSG) donor sites in a swine model (Part A) and a clinical trial (Part B). Part A: STSG donor sites in 4 piglets were treated with HAM or a clinically used conventional polyurethane (PU) foil (n=8each). Biopsies were taken on days 5, 7, 10, 20, 40, and 60 and investigated immunohistochemically for alpha-smooth muscle actin (αSMA: wound contraction marker), von Willebrand factor (vWF: angiogenesis), Ki-67 (cell proliferation), and laminin (basement membrane integrity). Part B: STSG donor sites in 45 adult patients (16 female/29 male) were treated with HAM covered by PU foam, solely by PU foam, or PU foil/paraffin gauze (n=15each). Part A revealed no difference in the rate of wound closure between groups. HAM showed improved esthetic results and inhibitory effects on cicatrization. Angioneogenesis was reduced, and basement membrane formation was accelerated in HAM group. Part B: no difference in re-epithelialization/infection rate was found. HAM caused less ichor exudation and less pruritus. HAM has no relevant advantage over conventional dressings but might be a cost-effective alternative.

Burns ◽  
1994 ◽  
Vol 20 (2) ◽  
pp. 115-117 ◽  
Author(s):  
J.W. Canady ◽  
J.M. Hiebert ◽  
M.M. Mani ◽  
P. Briscoe ◽  
S.A. Thompson

2013 ◽  
Vol 132 ◽  
pp. 50-51
Author(s):  
Pamela C. Masella ◽  
Eric M. Balent ◽  
Terri L. Carlson ◽  
Karen W. Lee ◽  
Lisa M. Pierce

2015 ◽  
Vol 2015 ◽  
pp. 1-8 ◽  
Author(s):  
Sukhontha Hasatsri ◽  
Apichai Angspatt ◽  
Pornanong Aramwit

We developed the novel silk fibroin-based bilayered wound dressing for the treatment of partial thickness wounds. And it showed relevant characteristics and accelerated the healing of full-thickness wounds in a rat model. This study is the clinical evaluation of the bilayered wound dressing to confirm its safety and efficacy for the treatment of split-thickness skin donor sites. The safety test was performed using a patch model and no evidence of marked and severe cutaneous reactions was found. The efficacy test of the bilayered wound dressing was conducted on 23 patients with 30 split-thickness skin graft donor sites to evaluate healing time, pain score, skin barrier function, and systemic reaction in comparison to Bactigras. We found that the healing time of donor site wounds treated with the bilayered wound dressing (11 ± 6 days) was significantly faster than those treated with Bactigras (14 ± 6 days) (p=10-6). The wound sites treated with the bilayered wound dressing showed significantly less pain and more rapid skin functional barrier recovery than those treated with Bactigras (p=10-5). Therefore, these results confirmed the clinical safety and efficacy of the bilayered wound dressing for the treatment of split-thickness skin graft donor sites.


2013 ◽  
Vol 31 (1) ◽  
pp. 104-116 ◽  
Author(s):  
Tippawan Siritientong ◽  
Apichai Angspatt ◽  
Juthamas Ratanavaraporn ◽  
Pornanong Aramwit

2020 ◽  
Vol 33 (12) ◽  
pp. 636-641
Author(s):  
Mojtaba Vaheb ◽  
Bahareh Mohajer Kohestani ◽  
Maryam Karrabi ◽  
Maryam Khosrojerdi ◽  
Mahtab Khajeh ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document